IMPORTANCE OF OMEGA-3 FOR GOLF AND ATHLETIC PERFORMANCE
Athletes and Non-Athletes are Severely Deficient in Omega-3
“Western diets are deficient in omega-3 fatty acids, and have excessive amounts of omega-6 fatty acids compared with the diet on which human beings evolved and their genetic patterns were established.”
Simopoulos, AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother. 2002;56:365–379“The healthy ratio of omega-6 to omega-3 essential fatty acid intake is 1:1. Because of the changes in diet in the industrial world (increased human consumption of grains and grain products and grain fed industrially farmed meat vs wild game) there is widespread deficiency in the intake of omega-3 fatty acids and overconsumption of omega-6. The omega-6 to omega-3 intake ratio is now very dangerously at 20:1 or higher.”
Eaton, Eaton & Konner. Paleolithic nutrition revisited: A twelve year retrospective on its nature and implications. Eur J. of Clin Nutr. 1997: 51;207-216Omega-3 Supplementation Reduces Pain
Fish oil supplementation reduces exercise-induced inflammation, decreases delayed onset muscle soreness, increases the rate of recovery, and reduces the risk for infection due to immunodeficiency.
Fish oil supplementation is associated with improved cognitive abilities including reaction time, decision making, and stabilizing mood.
“The cardioprotective effects of omega-3 fatty acids are ascribed to improvements in various cardiovascular risk factors including a reduction in blood-platelet aggregation (Mori et al., 1997; Phang et al., 2012), decreased inflammation, enhanced endothelial function, positive changes in blood lipids, and decreased blood pressure.”
Mickleborough, T.D. Omega-3 polyunsaturated fatty acids in physical performance optimization. Int J Sport Nutr. Exerc. Metab. 2013; 23: 83-96“The exception is the omega-3 PUFAs; controlled trials demonstrate their efficacy in reducing joint pain associated with inflammatory conditions, including rheumatoid arthritis (RA), inflammatory bowel disease, and dysmenorrhea.”
Goldberg RJ, Katz J. A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain. Pain 129 (2007) 210-233.“The agent best documented by hundreds of references in the literature for its anti-inflammatory effects is omega-3 essential fatty acids (EFAs or essential fatty acids [EPA, DPA, DHA) found in fish and in pharmaceutical-grade fish oil supplements.”
“There is extensive documentation in the rheumatology, ophthalmology, and cardiovascular literature on the beneficial anti-inflammatory affects of high-dose fish oil in the reduction of joint pain from rheumatoid and osteoarthritis, and also major positive affects on … coronary artherosclerosis, which is now considered an inflammatory disease.”
Maroon, JC, Bost JW. Omega-3 fatty acids (fish oil) as an anti-inflammatory: an alternative to nonsteroidal anti-inflammatory drugs for discogenic pain. Surgical Neurology. 2006;65(3):326-331Omega-3 Supplementation Reduces Chronic Pain
“Omega-3 fatty acid supplementation offers a clinically meaningful and time-dependent reduction in chronic pain.”
“Omega-3 fatty acids may be best positioned as a safer adjunct or as a long-term strategy in the management of chronic pain.”
“This finding is consistent with previous reviews suggesting that prolonged supplementation is necessary to achieve clinically meaningful analgesic effects [because it takes months for the omega-3 fatty acids to be incorporated into cell membranes and to increase the inflammation resolving pathways that are dependent upon omega-3 fatty acids.]”
Xie et al (2025) Effects of omega-3 fatty acids on chronic pain: a systematic review and meta-analysis. Frontiers in Medicine DOI 10.3389/fmed.2025.1654661Omega-3 Supplementation Reduces Inflammation and Improves Both Recovery and Athletic Performance.
“These results form a body of evidence over more than 10 years, showing that omega-3 fatty acids are a strong, evidence-based nutritional tool for reducing the effects of post-exercise inflammation, supporting functional recovery, and sustaining long-term athletic performance.”
Li & Zhang (2026) Effects of Omega-3 Supplementation on Inflammation and Recovery in Sports: A Meta-Analysis. The FASEB Journal doi.org/10.1096/fj.202504783ROmega-3 Supplementation Increases Muscle Strength and Performance and Decreases Age-Related Decline
“Omega-3 polyunsaturated fatty acids (n-3 PUFAs), specifically the most biologically active (eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)), have well-documented health promoting effects, including, but not limited to, controlling inflammatory processes in the human body and supporting cardiovascular and cognitive health and visual processes.”
“On the basis of EMG, a greater muscle activation was noted in the fish oil-supplemented groups, confirming the contribution of n-3 PUFAs to increasing muscle strength through their effect on neuromuscular conduction.”
Tomcyzk, M. (2024) Omega-3 Fatty Acids and Muscle Strength – Current State of Knowledge and Future Perspectives. Nutrients doi.org/10.3390/nu16234075“In the FO [fish oil] group, the omega-3 index, EPA and DHA increased by 73%, 332% and 64%, respectively, while there was no change in the placebo group. HGS [hand grip strength] significantly improved in the FO group and did not change in the placebo group. The change in HGS was positively correlated with the relative change in EPA and EPA:AA ratio.”
“For in-season athletes, the addition of LC n-3 supplementation to a dietary regime increases blood LC n-3 status and may preserve or improve muscular performance while in-season.”
Heileson et al. (2022) The Impact of Long-Chain Omega-3 Polyunsaturated Fatty Acid Supplementation on Body Composition, Strength, and Power in Collegiate Athletes. J of Exercise and Nutrition. 5 (1): 5, pgs 1-9.Omega-3 Supplementation Improves Joint Health, Reduces Pain, and Improves Quality of Life
“This study demonstrated that Omega-3 fatty acid supplementation for 12 weeks resulted in significant improvement in joint health, reduction in pain severity, decreased bleeding frequency, and enhanced quality of life among patients with hemophilia. These findings align with existing evidence supporting the anti-inflammatory and analgesic properties of Omega-3 fatty acids observed in other musculoskeletal conditions.”
Sultana et al. (2025) Effect of Omega-3 Fatty Acid Supplementation on Joint Health and Quality of Life in Patients with Hemophilia. Journal of Teachers Association 38(1): 314-318.Omega-3 Supplementation Reduces Inflammation and Cartilage Destruction and Improves Joint Mobility in Osteoarthritis
“More specifically, omega-3 polyunsaturated fatty acids (PUFA) have demonstrated an influential role in the progression of OA, resulting in the reduction of cartilage destruction, inhibition of pro-inflammatory cytokine cascades, and production of oxylipins that promote anti-inflammatory pathways.”
“This is due to their anti-inflammatory properties, which result in a positive influence on pain, joint mobility, and cartilage formation.”
Shawl et al. (2024) Omega-3 Supplementation and Its Effects on Osteoarthritis. Nutrients doi.org/10.3390/nu16111650Omega-3 Supplementation Increases Muscle Function, Reduces Muscle Loss, and Improves Weight Loss
“Omega-3 fatty acids could increase protein anabolism, reduce protein catabolism in the context of exercise-related muscle damages, and could induce beneficial mitochondrial modifications.”
“In obesity, omega-3 fatty acids participate in weight loss and its maintenance, and can help decrease insulin resistance.”
“In sarcopenia atrophic conditions, omega 3 fatty acids allow muscle mass and function maintenance. In cancer cachexia, omega 3 fatty acids are more efficient at the pre-cachectic stage, as they can reduce protein catabolism and increase protein anabolism.”
“These effects are mediated by EPA and DHA, whose sources are solely of marine origins. As marine resources are overexploited, finding diverse sources of omega-3 fatty acids is crucial.”
Doussat et al. (2024) Dietary omega-3 fatty acids and skeletal muscle metabolism: a review of clinical and preclinical studies.Omega-3 Supplementation Significantly Increases Energy Expenditure and Fat Loss During Exercise and at Rest and Significantly Lowers Triglycerides
“The results demonstrated that fish oil supplementation significantly increased resting metabolic rate by 14%, energy expenditure during exercise by 10%, and the rate of fat oxidation during rest by 19% and during exercise by 27%.”
“In addition, FO consumption lowered triglyceride levels by 29% and increased lean mass by 4% and functional capacity by 7%.”
Logan & Spriet (2015) Omega-3 Fatty Acid Supplementation for 12 Weeks Increases Resting and Exercise Metabolic Rate in Healthy Community-Dwelling Older Females. PLoS ONE doi:10.1371/journal.pone.0144828Omega-3 Supplementation Improves Muscle Function and Physical Performance
“Growing evidence from randomized controlled trials (RCTs) suggests beneficial effects of omega-3 PUFAs on muscle function, including physical performance parameters in mid to later life.”
“Among various dietary compounds, omega-3 polyunsaturated fatty acids (PUFAs) are gaining growing attention for their potential effects on muscle membrane composition and muscle function. Indeed, several pathways are enhanced, such as an attenuation of pro-inflammatory oxidative stress, mitochondrial function, activation of the mammalian target of rapamycin (mTOR) signaling and reduction of insulin resistance.”
Azzolino et al. (2024) Omega-3 polyunsaturated fatty acids and physical performance across the lifespan: a narrative review. Frontiers in Nutrition doi: 10.3389/fnut.2024.1414132Omega-3 Supplementation Improves Neuromuscular Performance and Reduces Cognitive Decline.
“In this review, we will present the biochemical mechanisms of action of omega-3 fatty acids through their mediators, specialized pro-resolving mediators [synthesized from omega-3], which have anti-inflammatory activity.”
“In a randomized study on footballers, Gravina et al. highlighted an improvement in aerobic capacity following 4 weeks of omega-3 supplementation. Black’s group showed a moderate but significant improvement in muscle pain, which translated into improved explosive power.”
A study by Guzman et al., in which 24 professional footballers were supplemented with 3.4 g of DHA per day for four weeks, produced an improvement in neuromotor skills, particularly in neural RT [reaction time].
“In this view, Godos and co-workers suggested in a meta-analysis that fish consumption is associated with a lower risk of cognitive impairment/decline in a dose–response manner.”
“The anti-inflammatory action of the two omega-3 fatty acids DHA and EPA is well established, even if unrelated to sports, solidifying the scientific rationale that justifies their integration.”
“It remains to be defined whether we want to consider these supplements as directly ergogenic (i.e., capable of directly improving performance) or as supplements that put the athlete in the best health conditions and, therefore, have a positive influence on performance.”
Cannataro et al. (2024) Omega-3 and Sports: Focus on Inflammation. Life 14,1315 https://doi.org/10.3390/life14101315Supplementation with Omega-3 Decreases Fat Mass, Increases Muscle Mass, and Decreases Cortisol.
“Conclusion: 6 wks of supplementation with fish oil significantly increased lean mass and decreased fat mass. These changes were significantly correlated with a reduction in salivary cortisol following fish oil treatment.”
Noreen et al. (2010) Effects of supplemental fish oil on resting metabolic rate, body composition, and salivary cortisol in healthy adults. Journal of International Society of Sports Nutrition 7:31Omega-3 Supplementation Improves Sport Performance, Reduces Inflammation, Increases Antioxidants, Decreases LDL and Increases HDL Cholesterol, and Increases Neuro-Biomarkers of Motor Control, Agility, Balance, Reaction Time, and Positive Mood.
“Physical performance tests demonstrated greater improvements in muscular strength, power, speed, agility, and reaction-based performance in the omega-3 group compared to controls.”
“The experimental group [fish oil supplement group] showed significant improvements in the lipid profile, with decreases in LDL and triglyceride levels and an increase in HDL levels.”
“Levels of the inflammatory cytokines IL-6 and TNF-α were significantly reduced, while GSH [glutathione] levels increased and MDA [malondialdehyde] levels decreased, indicating an enhanced antioxidant status.”
“The neuro-biomarker analysis revealed increased levels of BDNF, dopamine, and serotonin.”
“Conclusions: These findings suggest that omega-3 supplementation, when combined with resistance training, has a multi-systemic enhancing effect on both physiological markers and physical performance. This combination may represent a promising strategy for optimizing athletic adaptations and recovery in physically active populations.”
Okut et al. (2025) The Effects of Omega-3 Supplementation Combined with Strength Training on Neuro-Biomarkers, Inflammatory and Antioxidant Responses, and the Lipid Profile in Physically Healthy Adults. Nutrients 17, 2088. doi.org/10.3390/nu17132088Omega-3 Supplementation Enhances Cardiopulmonary Function, Exercise Recovery, Cognitive Function, Injury Recovery, and Strength and Power.
“Omega-3 fatty acids (n-3), recognized for their anti-inflammatory and brain health benefits, are being studied to enhance cognitive function, aid physical recovery, and reduce injury rates among military service members (SMs). Given the unique demands faced by this tactical population, this systematic review aims to evaluate the evidence of n-3 to support physical and mental resilience and overall performance.”
“The results highlighted evidence-based findings in five key areas where omega-3 fatty acids are being evaluated to benefit military service members. These key areas include cardiopulmonary function, exercise recovery, cognitive function, injury recovery, and strength and power.”
“While existing research suggests promising benefits, the most significant evidence was seen with cardiopulmonary function, exercise recovery, and cognitive function.”
Rittenhouse et al. (2025) Examining the Influence of Omega-3 Fatty Acids on Performance, Recovery, and Injury Management for Health Opitimization: A Systematic Review Focused on Military Service Members. Nutrients 17, 307. doi.org/ 10.3390/nu17020307Omega-3 Supplementation in Athletes Improves Recovery, Improves Cardiovascular and Strength Training Adaptations, Improves Mood, Reduces Fatigue, Improves Cognitive Function, and Improves Overall Health Status.
“Low O3I [omega-3 index] is common in many populations, mainly reflecting a low intake of fatty fish. Existing studies indicate that both professional and amateur athletes have O3I values below optimal.”
“Considering this low O3I [Omega-3 Index] , as well as the scarcity of EPA and DHA in foods and their pleiotropic effects, including but not limited to the control of inflammation, support of cognitive function, neuroprotection, maintaining muscle mass after injury and enhancement of training adaptations and recovery from exercise [19–27], the question arises about whether athletes should consider using supplements that contain EPA and DHA.”
“Considering their broad spectrum of actions, including but not limited to supporting nervous system function, maintaining muscle mass after injury and improving training adaptations and the lack of adverse effects at dosing regimens that might be recommended (e.g., 2 g/day), it seems reasonable for athletes to consider using EPA and DHA supplements. These would also benefit their long-term health.”
Tomczyk et al (2023) Athletes Can Benefit from Increased Intake of EPA and DHA – Evaluating the Evidence. Nutrients 15, 4925 doi.org/10.3390/nu15234925Supplementation with Omega-3 Improves Recovery and Performance for Amateurs and Athletes
“This review identified evidence to support a role of EPA/DHA in improved performance such as enhanced endurance, markers of functional response to exercise, enhanced recovery or neuroprotection.”
“The majority of evidence stems from studies in amateurs rather than athletes, although most recommendations for EPA/DHA supplementation for improved performance are made for athletes. In practical terms, athletes, and likely more so, amateurs may benefit from the consumption/supplementation of EPA/DHA.”
“Several studies suggest a potentially beneficial effect of EPA/DHA on performance by improved endurance capacity and delayed onset of muscle soreness, as well as on markers related to enhanced recovery and immune modulation.”
Thielecke & Blannin (2020) Omega-3 Fatty Acids for Sport Performance – Are They Equally Beneficial for Athletes and Amateurs? A Narrative Review. Nutrients doi:10.3390/nu12123712It Takes 3-4 Months of Daily Supplementation with Omega-3 to Become Fully Sufficient and Experience the Full Benefits
“A meta-analysis of 16 studies at 3–4 months showed significant effects for four of six pain outcomes: patient assessed pain, morning stiffness, number of painful and/or tender joints, and NSAID consumption.”
“Previous reports suggest that the therapeutic effects of omega-3 PUFAs are usually manifest after approximately 3 months (Stamp et al., 2005). We hypothesized that patients taking omega-3 PUFA supplementation for 2 months or less would not benefit significantly (for pain reduction).”
Goldberg RJ, Katz J. A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain. Pain 129 (2007) 210-233.
IMPORTANCE OF OMEGA-3 FATTY ACIDS FOR OVERALL HEALTH
Supplementing with Omega-3 Fatty Acids Improves Overall Health and Quality of Life and Reduces the Development of Chronic Diseases. Research Shows that Supplementing with Omega-3 Improves Immune Function, Improves Inflammation Resolution and Decreases Systemic Inflammation, Improves Blood Sugar, Improves Fat Loss, Decreases Age-Related and Disease-related Muscle Loss, Decreases Arthritis-Related Joint Destruction and Pain, Decreases Cancer Incidence and Improves Cancer Survival, Decreases Cardiovascular Disease Incidence and Improves Survival, Improves Pregnancy and Newborn Outcomes, Improves Moods and Reduces Depression and Anxiety, Improves Digestive Health and Reduces IBS and Crohn’s Inflammation and Pain.
Supplementing with Omega-3 Increases Fat Weight Loss and Improves Triglyceride Levels
“The results demonstrated that fish oil supplementation significantly increased resting metabolic rate by 14%, energy expenditure during exercise by 10%, and the rate of fat oxidation during rest by 19% and during exercise by 27%.”
“In addition, FO consumption lowered triglyceride levels by 29% and increased lean mass by 4% and functional capacity by 7%.”
Logan & Spriet (2015) Omega-3 Fatty Acid Supplementation for 12 Weeks Increases Resting and Exercise Metabolic Rate in Healthy Community-Dwelling Older Females. PLoS ONE doi:10.1371/journal.pone.0144828“Omega-3 fatty acids promote weight loss and fat loss by inhibiting fat synthesis, enhancing fat break-down and thermogenesis (fat burning), and preventing fat storage.”
Li & Huang. Anti-obesity effects of conjugated linoleic acid, docosahexaenoic acid, and eicosapentaenoic acid. Mol Nutr Food Res. 2008 52: 631-45Omega-3 Essential for Immune Function and Protection from Colds, Flus, and COVID
“Specialized pro-resolving mediators (SPMs) are enzymatically derived from essential fatty acids and have important roles in orchestrating the resolution of tissue inflammation — that is, catabasis. Host responses to tissue infection elicit acute inflammation in an attempt to control invading pathogens [and repair tissue].”
“SPMs are lipid mediators that are part of a larger family of pro-resolving molecules, which includes proteins and gases, that together restrain inflammation and resolve the infection [and/or tissue damage].”
“These immunoresolvents are distinct from immunosuppressive molecules as they not only dampen inflammation but also promote host defence.”
“Because SPMs engage endogenous resolution pathways, these mediators have the potential to both decrease pathogen-mediated inflammation and enhance host defence, which distinguishes SPMs from immunosuppressive agents.”
“Non-infectious inflammation is a common and often devastating cause of human disease. Most current therapies rely on blunting the inappropriate immune response through the use of anti-inflammatory medications, all of which have significant undesirable side effects, including increasing the host susceptibility to infection.”
“ARDS [acute respiratory distress syndrome/cytokine storm] is a prevalent condition with high rates of morbidity and mortality. It is characterized by an overly robust inflammatory response to infection (for example, pneumonia and sepsis) or injury that fills the alveoli with oedema and pus, resulting in life-threatening respiratory failure. Many unsuccessful attempts have been made to therapeutically target an inflammatory pathway to limit this over-exuberant host response.”
Basil & Levy. (2016) Specialized pro-resolving mediators: endogenous regulators of infection and inflammation. Nature Reviews Immunology 16: 51-67.“Long chain omega-3 PUFAs have been shown to possess immunomodulatory effects. It appears that the EPA and DHA membrane composition of immune cells can be altered with long term ingestion of omega-3 PUFAs, which can influence phagocytosis, T-cell signaling, and antigen-presenting capabilities.”
“Omega-3 fatty polyunsaturated fatty acids (PUFAs) have been shown to decrease the production of inflammatory eicosanoids, cytokines, and reactive oxygen species; have immunomodulatory effects; and attenuate inflammatory diseases.”
Mickleborough, T.D. Omega-3 polyunsaturated fatty acids in physical performance optimization. Int J Sport Nutr. Exerc. Metab. 2013; 23: 83-96“There are three main properties of macrophage [immune cell] biology that have been identified to be altered by omega-3 fatty acids: the production and secretion of cytokines and chemokines, the capacity of phagocytosis, and the polarization into classically activated or alternatively activated macrophages.”
“Ten volunteers were given fish oil supplementation containing 26% EPA and 54% DHA daily for two months. Thereafter, the phagocytic capacity of the neutrophils in the blood was increased by 62%.”
Gutierrez, S. Effects of Omega-3 Fatty Acids on Immune Cells. Int J Mol Sci. 2019; 20: 5028; doi:10.3390/ijms20205028“Targeting individual pro-inflammatory cytokines may not be sufficient to prevent COVID-19 progression.”
“Importantly, SPMs [specialized pro-resolving mediators derived from Omega-3 fatty acids] terminate self-sustaining inflammatory processes, such as those induced by COVID-19, by broadly inhibiting proinflammatory cytokine production and promoting a return to tissue homeostasis.”
“Moreover, conventional anti-inflammatory agents such as NSAIDs and COX-2 inhibitors, while limiting the eicosanoid storm, may be “resolution toxic” as they indiscriminately inhibit eicosanoid pathways that produce resolution mediators and thereby prevent active resolution.”
Panigrahy et al. (2020) Inflammation Resolution: a dual prolonged approach to averting cytokine storms in COVID-19? Cancer and Metastasis Reviews 39: 337-340.“The inclusion criteria were the age between 35 and 85 years, diagnosis of COVID-19 confirmed by a positive RT-PCR nasopharyngeal swab, as well as symptoms such as severe pneumonia, fever, fatigue, dry cough, respiratory distress, and indicated for enteral nutrition.”
“The intervention group had significantly higher 1-month survival rate compared with the control group (21% vs 3%).” *That is a 700% increase in chance of survival!!!
“Omega-3 polyunsaturated fatty acids (n3-PUFAs) are important mediators of inflammation and acquired immune responses and can amplify anti-inflammatory responses.”
Doaei et al. (2021) The effect of omega-3 fatty acid supplementation on clinical and biochemical parameters of critically ill patients with COVID-19: a randomized controlled trial. J Transl Med 19:128Omega-3 Sufficiency Reduces Risk of Cardiovascular Disease and Mortality
“Due to the overwhelming evidence of benefit, the American Heart Association now recommends the use of omega-3 fatty acid supplements for the primary and secondary prevention of coronary heart disease.”
Bronas, U. & Dengel, D. Influence of vascular oxidative stress and inflammation on the development and progression of atherosclerosis. Am J Lifestyle Med. 4 (6) 521-34“Omega-3 consumption has been shown to confer positive health effects on several key age-related biological processes, including improved CV and immune function, enhanced cognition, and augmented neuromuscular function. Lower blood pressure (BP) levels and slower resting heart rates are associated with reduced risks for CVD and premature mortality. Approximately 3 g of DHA+EPA per day will lower systolic BP by a mean of 4.5 mm Hg in people with hypertension and 2 mm Hg in people with normal BP at baseline and will decrease resting heart rate by approximately 5 beats/min.”
“Conclusion: Higher DHA levels were associated with significant risk reductions in all-cause mortality, as well as reduced risks for deaths due to CV disease, cancer, and all other causes. The findings strengthen the hypothesis that DHA, a marine-sourced omega-3, may support CV health and lifespan.”
“The vagus nerve plays a fundamental role in CV and brain health and in optimal function of the immune and gastrointestinal systems. People with higher vagal tone have been shown to be at lower risk of all-cause and CVD mortality during long-term follow-up. Supplementing with omega-3 has been shown to augment vagal tone in a dose-dependent manner.”
“To increase an omega-3 index of 5.4% to 8% would require consumption of approximately 1000 mg/d of DHA+EPA, and to go from the lowest quintile in the current study, with an omega-3 index 3.5%, to 8% would require approximately 1600 mg/d of DHA+EPA.”
O’Keefe, E. et.al. (2024) Circulating Docosahexaenoic Acid and Risk of All-Cause and Cause-Specific Mortality. Mayo Clinic Proceedings.“Supplementation was associated with reduced risk of MI [Myocardial Infarction]; CHD [Coronary Heart Disease] events; fatal MI; and CHD mortality.”
“Supplementation with EPA and DHA is an effective lifestyle strategy for CVD [Cardiovascular Disease] prevention, and the protective effect probably increases with dosage.”
Bernasconi et al. (2020) Effect of Omega-3 Dosage on Cardiovascular Outcomes: An Updated Meta-Analysis and Meta-Regression of Intervention Trials. Mayo Clinic Proceedings http://creativecommons.org/licenses/by-nc-nd/4.0/“After adjustment for demographic, cardiovascular, lifestyle, and dietary factors both individual and combined levels of EPA, DPA, and DHA were associated with lower total mortality.”
“For cause-specific deaths, all 3 PUFAs were associated with lower CVD mortality and their combined levels were associated with 35% lower risk across quintiles.”
“Among CVD subtypes, DHA seemed most strongly related to CHD death (40% lower risk), especially arrhythmic CHD death (45% lower risk), whereas DPA was most strongly related to stroke death (47% lower risk).”
“Across quintiles, individuals with higher EPA, DPA, and DHA levels had 17%, 23%, and 20% lower risk, respectively, and those with higher total 3-PUFA levels had 27% lower risk.”
*Note the increased combined effect of EPA, DPA, and DHA – OmegA+D Sufficiency™
is one of the few Omega-3 supplements that includes DPA.
*OmegA+D Sufficiency™
delivers 1640 mg of EPA+DHA plus 180 mg of DPA per 4 capsules!!
Mozaffarian et al. Plasma phospholipid long chain n-3 fatty acids and total and cause-specific mortality in older adults. Ann Intern Med. 2013;158:515-525“Statin Drugs (e.g. lipitor, crestor, etc) were 10 times more effective at lowering cholesterol than omega-3 fatty acids (20% vs 2% reduction in total cholesterol).”
“However, omega-3 fatty acids were 44% more effective than statin drugs in reducing death from cardiac events.”
Studer et al. 2005 Effect of Different Antilipidemic Agents on Mortality: A Systematic Review. Archives of Internal Medicine. April 11, 725-730Omega-3 Supplementation Improves Erectile Function
“The results of western blot analysis revealed that systemically administered omega-3 fatty acids ameliorated the cavernosal molecular environment.”
“Our study suggests that omega-3 fatty acids improve intracavernosal pressure and have a beneficial role against pathophysiological consequences such as fibrosis or hypoxic damage on a CPI rat model, which represents a structural erectile dysfunction model.”
Shim, J.S. et al. Effects of Omega-3 Fatty Acids on Erectile Dysfunction in a Rat Model of Atherosclerosis-induced Chronic Pelvic Ischemia. Journal Korean Med Sci 2016 Apr; 31(4): 585-589Omega-3 Lowers Risk of Cancer
“Omega-3 fatty acids lower the risk of cancer through their suppressing effect on the biosynthesis of eicosanoids [molecules from omega-6 fatty acids (seed oils) that promote inflammation, suppress the immune cells that eliminate cancer cells, and stimulate cancer cell growth].”
Larsson, SC, et.al. Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am J Clin Nutr 2004;79:935-45.“By affecting cell membrane composition, metabolism, signal pathways, and by direct control of gene expression, sufficient omega 3 essential fatty acid levels play a key role in the prevention of human diseases such as obesity, diabetes, cancer, neurological and brain disorders, and heart disease.”
Ntambi, J.M. & Bene, H. Polyunsaturated fatty acid regulation of gene expression. J Mol Neuroscience 2001 Apr-Jun; 16 (2-3): 273-8Omega-3 Fatty Acids Essential for Brain and Emotional Health
“Vitamin D and Omega-3 fatty acids modulate depression pathways, influencing neurotransmission and reducing inflammation.”
“Observational studies and randomized trials support their efficacy, particularly in cases of deficiency.”
“Integrative approaches incorporating these nutrients into care plans enhance therapeutic outcomes.”
“Vitamin D modulates neurotransmitter activity, reduces neuroinflammation, and influences neuroplasticity, enhancing cognitive function and mood regulation. Omega-3 fatty acids, particularly EPA and DHA, exhibit anti-inflammatory properties, optimize serotonergic transmission, and stabilize neuronal membranes. Clinical evidence suggests that supplementation with these nutrients can significantly reduce depressive symptoms, particularly in patients with comorbid nutritional deficiencies. However, variability in study designs and dosages limits the generalizability of findings.”
Raza et al. (2025) Nutritional interventions in depression: The role of vitamin D and omega-3 fatty acids in neuropsychiatric health. Clinical Nutrition Vol 45, Feb, 270-278“Among older adults, higher phospholipid long-chain omega-3 PUFA content was associated with lower prevalence of subclinical infarcts and better white matter grade on MRI. Our results support the beneficial effects of fish consumption, the major source of long-chain omega-3 PUFAs, on brain health.”
Virtanen et al. Circulating Omega-3 Polyunsaturated Fatty Acids and Subclinical Brain Abnormalities on MRI in Older Adults: The Cardiovascular Health Study. J Am Heart Assoc. 2013;2:e000305 doi: 10.1161/JAHA.113.000305)“A Purdue University study showed that kids low in Omega-3 essential fatty acids are significantly more likely to be hyperactive, have learning disorders, and to display behavioural problems.”
Stevens, LJ et. al. Omega-3 fatty acids in boys with behavior, learning, and health problems. Physiol Behav. 1996 59(4/5) 915-920.“The omega-3 polyunsaturated fatty acids (PUFAs) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are key dietary components investigated extensively in relation to psychiatric outcomes, owing to the therapeutic potential of their ever-expanding repertoire of potent bioactive derivatives. Despite the different bioactivity between EPA and DHA, there is a robust biological basis in support of their anxiolytic and antidepressant potential, comprising modulation of neuronal membrane properties, receptor expression and neurotransmission, antioxidant, anti-inflammatory and pro-resolving activity, and promotion of neuroplasticity and neuroprotection. These properties may modulate brain homoeostasis, which in turn is linked to mood, making it imperative to understand the role of omega-3 PUFAs in mental ill-health.”
“Preclinical and epidemiological studies have consistently associated anxious and depressive states with poor omega-3 PUFA status. Correcting the latter by supplementation improves mood profiles.”
Kelaiditis et al. (2023) Effects of long chain omega-3 polyunsaturated fatty acids on reducing anxiety and/or depression in adults; A systematic review and meta-analysis of randomised controlled trials. Prostaglandins, Leuokotrienes and Essential Fatty Acids Vol 192, 102572.“Nutrition plays a vital role in the onset of depression, its severity, and its duration. Studies suggest that nutrition-deficient diets lacking omega-3 fatty acids are associated with higher risks of compromised mental health. Omega-3 long-chain polyunsaturated fatty acids (PUFA), including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are dietary fats found in fish oil are known for their health benefits in fetal development and healthy aging. At the same time, these marine oils are considered vital for brain health because 20% of the brain’s dry weight comprises polyunsaturated fatty acids as a major structural component of neuronal cell membrane phospholipids.”
“Similarly, the effect of omega-3 fatty acid supplementation in alleviating depressive symptoms can be associated with many published studies—Ryukyus Child Health Study elucidated the inverse association between fish intake and depression; eating less seafood was associated with reduced low omega-3 intake and higher rates of depression during pregnancy [26,27]. Similarly, another investigation into bipolar depression revealed that omega-3 fatty acids may be useful when used as a supplement for depressive symptoms in the patient cohort and that EPA-supplemented food could help relieve their depressive symptoms.”
“A total of 165 patients suffering from mild to moderated depression were randomized to receive omega-3 fatty acid supplementation, an antidepressant (single agent), or a combination of an antidepressant and omega-3 fatty acid supplementation. The clinical features of depression were assessed using the Hamilton Depression Rating Scale (HDRS) during the follow-up period. A statistically significant improvement in depressive symptoms was observed from baseline to first, second and third follow-ups within each treatment arm as measured by HRDS scores.”
“This illustrated that administered antidepressants (fluoxetine, escitalopram, or sertraline), and omega-3 fatty acid supplements were efficacious in treating depression alone as well as in combination.”
Mehdi et al (2023) Omega-3 Fatty Acids Supplementation in the Treatment of Depression: An Observational Study. Journal of Personalized Medicine Jan 27;13(2):224IMPORTANCE OF SUPPLEMENTING OMEGA-3 and VITAMIN D and A TOGETHER: WHY OMEGA+D SUFFICIENCY™ IS SO UNIQUELY BENEFICIAL
“Vitamin A and vitamin D balance, enhance, and contain each other through the retinoid X receptor (RXR).”
“Because they share a receptor, if we supplement either vitamin D or vitamin A in an unbalanced fashion, we create a functional deficiency of the one not supplemented.”
“Low blood levels of vitamin D, vitamin A, and carotenoids are all correlated with greater risk of heart disease.”
Levine, SA. The importance of a balanced approach to vitamin D supplementation. Journal of Orthomolecular Medicine. 2011;26(1):15-20.“In summary, we describe a unique and unexpected facet of intermolecular cross-talk between VDR and RXR and demonstrate that RXR actively participates in RXR-VDR-mediated gene transcription by directly recruiting coactivators in response to 1,25-(OH)2D3.”
In layperson terms vitamin A (retinoid) is required to activate the expression of vitamin D controlled genes. In other words, without sufficient amounts of vitamin A, the actions of vitamin D can be impaired or even blocked. Vitamin A and Vitamin D work synergistically.
Burris, et al. Retinoid X Receptor Is a Nonsilent Major Contributor to Vitamin D Receptor-Mediated Transcriptional Activation. Molecular Endocrinology 17: 2320–2328, 2003“This would imply that the policy of giving vitamin D supplement alone in pregnancy instead of cod liver oil would need adjustment. Cod liver oil, as natural supplement of vitamin A and vitamin D, is well know for its beneficial effects on the growth of infants and children.”
Ng et al. Vitamin D and vitamin A receptor expression and the proliferative effects of ligand activation of these receptors on the development of pancreatic progenitor cells derived from human fetal pancreas. 2011 Stem Cell Rev 7 (1): 53–63“The large, randomized, double-blind, placebo controlled trial VITAL (vitamin D and omega-3 trial) recently confirmed that vitamin D and Omega-3 polyunsaturated fatty acid (PUFA) co-supplementation (VIDOM) can reduce the incidence of autoimmune diseases. Based on these relevant results, this commentary summarizes the molecular mechanisms behind the anti-inflammatory and immunomodulatory properties of vitamin D and omega-3 PUFAs.”
“We also describe the potential bidirectional interplay between vitamin D metabolism and omega-3 PUFA metabolism that underlies the rationale for VIDOM co-supplementation and that may contribute to enhance the anti- inflammatory and immunomodulatory actions of Vitamin D and omega-3 PUFAs when these compounds are administered in combination.”
“In this regard, the recent results of the VITAL study are of high clinical significance, since both vitamin D and omega-3 PUFAs are safe, well-tolerated, nontoxic and inexpensive nutritional supplements that may be particularly beneficial in high-risk individuals.”
“In light of the above, hypovitaminosis D and omega-3 PUFA deficiencies may represent key environmental risk factors for development of autoimmune diseases. Indeed, vitamin D and omega-3 PUFA deficiencies can be associated with an increase in systemic inflammation. Vitamin D and omega-3 PUFAs, when administered in combination (as VIDOM co-supplementation, may exert synergistic anti-inflammatory and imunomodulatory actions to a greater extent than when they are administered alone.”
“In fact, adequate circulating vitamin D and omega-3 PUFA concentrations may contribute to reduce systemic inflammation by enhancing a systemic anti-inflammatory state.”
“Accordingly, preliminary intervention studies and clinical trials demonstrated that VIDOM co-supplementation leads to significant benefits in different clinical settings, including insulin resistance and non-alcoholic fatty liver disease, prediabetes, type 2 diabetes mellitus associated with coronary heart disease, gestational diabetes mellitus, polycystic ovary syndrome, type 1 diabetes mellitus, inflammatory bowel disease, and autism spectrum disorder.”
“Such beneficial effects likely arise from the synergistic anti-inflammatory, antioxidant and immunomodulatory properties exerted by vitamin D and omega-3 PUFAs.”
Infante et al. (2022) The importance of vitamin D and omega-3 PUFA supplementation: a nonpharmacologic immunomodulation strategy to halt autoimmunity. Eur Rev Med and Pharm Sci 26:6787-6795“A significant reduction was observed in fasting glucose, insulin, homeostasis model assessment-beta cell function, weight and waist circumference in the co-supplementation group compared to the other three groups. Moreover, high-density lipoprotein-cholesterol levels increased significantly in the co-supplementation group compared to the other three groups [Vit D or Omega-3 alone or placebo].”
"Conclusion: Vitamin D and omega-3 co-supplementation improved fasting serum glucose, insulin, high-density lipoprotein-cholesterol level, homeostasis model assessment-beta cell function, weight and waist circumference. This co-supplementation can therefore be recommended for glycemic control.”
Rajabi-Naneeni et al. (2020) The effect of omega-3 and vitamin D co-supplementation on glycemic control and lipid profiles in reproductive-aged women with pre-diabetes and hypovitaminosis D: a randomized controlled trial. Dabetology & Met Syndr https://doi.org/10.1186/s13098-020-00549-9“A significant difference was observed in terms of reduction in anxiety and improvement in sleep quality in the co-supplementation compared to the other three groups. There was also a significant difference between the group receiving both supplements and the group receiving only placebos in terms of reduction in depression and stress.”
“Conclusion: Vitamin D and omega-3 co-supplementation improved depression, anxiety, and sleep quality in women of reproductive age with pre-diabetes and hypovitaminosis D. Therefore, these two supplements can be recommended for improving mental health.”
“Given their positive effects on mental health, the concurrent use of these two supplements can be further considered as a measure for preventing type-II diabetes.”
Rajabi-Naneeni et al. (2021) Effect of omega-3 and vitamin D co-supplementation on psychological stress in reproductive-aged women with pre-diabetes and hypovitaminosis D: A randomized controlled trial. Brain and Behaviour. DOI: 10.1002/brb3.2342Women with sufficient vitamin D levels had an 80% reduction in breast cancer incidence compared to those who had deficient vitamin D levels.
Lowe, LC et al. Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population. Eur J Cancer. 2005;41:1164-9.